Skip to main content

Table 1 Patient characteristics

From: Characterization of surface markers on extracellular vesicles isolated from lymphatic exudate from patients with breast cancer

Patient Gender Age Breast cancer NACT /Response# Breast surgery Axillary surgery Histology Tumor Size (mm) NHG ER+
(%)
PR+
(%)
HER2 LVI Positive
nodes
1 Female 72.4 Primary Yes/Grade 2 Mastectomy FNB- > ALND Lobular 60 2 100 80 Neg No 18
2 Female 86.1 Primary No Mastectomy FNB- > ALND Ductal 21 3 100 0 Neg Yes 3
3 Female 40.5 Primary No Mastectomy SNB- > ALND Ductal 4 3 30 0 Pos No 1
4 Female 45.3 Primary Yes/Grade 5 BCS FNB- > ALND Ductal 0 3 15 0 Pos No 0
5 Female 69.0 Primary No BCS SNB- > ALND Ductal 17 2 90 100 Neg No 1
6 Female 70.0 Primary No Mastectomy FNB- > ALND Ductal 43 2 95 95 Pos Yes 4
7 Female 66.3 Axillary recurrence No None FNB- > ALND Lobular N/A N/A 100 0 Neg N/A 2
  1. ALND axillary lymph node dissection, BCS Breast conserving surgery, ER estrogen receptor, FNB fine needle biopsy, HER2 human epidermal growth factor receptor 2, LVI lymphovascular invasion, NACT neoadjuvant chemotherapy, NHG Nottingham histological grade, PR progesterone receptor, SNB sentinel node biopsy. #according to Miller-Payne criteria for grading response.